Canada,United States : HITACHI MEDICAL enters into collaboration with Redlen Technologies.
Hitachi Medical Corporation has signed a deal with Redlen Technologies to collaboratively formulate a direct conversion semiconductor x-ray detector module needed for new photon counting computed tomography systems (PCCT), a next generation diagnostic medical imaging modality.
This deal includes that Hitachi and Redlen would cooperate to unveil a new multi-energy PCCT semiconductor detector module.
PCCT systems offer the potential for a breakthrough advance in CT diagnostic imaging performance through new capabilities which include material discrimination, higher image resolution, the addition of functional imaging and further radiation dose reduction.
Current commercial CT systems have limited to no knowledge of individual photon energies. Redlen has successfully developed semiconductor radiation sensors which have the ability to measure the unique energy of individual x-ray photons while operating at the very high count rates and stability levels necessary for x-ray computed tomography. The additional information provided by these advanced radiation sensors is a key to realizing next generation PCCT advances.
Hitachi and Redlen would cooperatively develop the data acquisition technology needed to process the order of magnitude higher amount of data received from these semiconductor radiation sensors and the packaging technology necessary for assembling the sensors into a detector module.
Mr. Glenn Bindley, President & CEO of Redlen commented on the agreement, "We are excited to partner with Hitachi, one of the original pioneers of medical CT technology, to pursue the enormous potential for advancement in medical CT that photon counting semiconductor sensors offer."
"PCCT is a promising next generation device which achieves radiation exposure reduction, high functionality and high degree of precision. It is expected to broaden the field of application. I hope this agreement will provide opportunities for us to further contribute to healthcare innovation." commented Masaya Watanabe, Vice President and Executive Officer, President & CEO of Healthcare Group and Healthcare Company at Hitachi, Ltd.
[c] 2016 Al Bawaba (Albawaba.com) Provided by SyndiGate Media Inc. ( Syndigate.info ).
|Printer friendly Cite/link Email Feedback|
|Date:||Mar 8, 2016|
|Previous Article:||Pakistan : Govt. procures Rs.1 billion land for Diamer Bhasha Dam.|
|Next Article:||China : CHINA needs generics to gain Brand-name Drug Quality.|